How Much Did Cellrox Raise?
Funding & Key Investors

Cellrox has secured $4.7M in total funding, with its most recent capital infusion of $4.7M described as a major strategic investment. This significant backing underscores the company's progress in the competitive mobile virtualization sector.

What is Cellrox?

Cellrox
SoftwareSecurity SoftwareMobile App Development

Cellrox is a pioneering technology firm specializing in mobile virtualization, renowned for its ThinVisor technology. This innovative solution allows for the simultaneous operation of multiple, secure, and independent virtual environments on a single mobile device. By establishing a robust separation between these virtual instances, Cellrox enhances security and enables seamless application transparency, permitting users to switch between distinct Virtual Mobile Instances with a single tap. Founded in 2011 by experienced entrepreneurs and technology leaders, the privately held company is headquartered in Israel.

How much funding has Cellrox raised?

Cellrox has raised a total of $4.7M across 1 funding round:

2013

Series A

$4.7M

Series A (2013): $4.7M with participation from Columbia Technology Ventures, Previz Venture Partners, and Runa Capital

Key Investors in Cellrox

Columbia Technology Ventures

Columbia Technology Ventures is an entity associated with Columbia University, likely focusing on investing in and commercializing technologies emerging from the university's research and development initiatives, particularly in areas of academic strength.

Previz Venture Partners

Previz Venture Partners is a venture capital fund that focuses on investing in innovative technology companies within the Medical Device and Healthcare ICT sectors. The fund targets early-stage companies that are post proof-of-concept and are approaching commercial viability, offering scalable solutions for large underserved markets.

Runa Capital

Runa Capital is an international venture capital firm that invests in deep tech and software, with a historical focus on European and North American technology companies and an increasing emphasis on Quantum Technologies.

What's next for Cellrox?

The recent major strategic investment signals a pivotal growth phase for Cellrox, likely aimed at scaling its operations, expanding market reach, and further developing its core ThinVisor technology. This capital infusion is expected to bolster its competitive position in the enterprise-level mobile security and virtualization market, potentially leading to new partnerships and enhanced product offerings.

See full Cellrox company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Customer Engagement PlatformsSoftware
Business Intelligence (BI) SoftwareSoftware
Healthcare SoftwareSoftwareHealthcare ServicesMedical Laboratories & Imaging Centers
Healthcare SoftwareSoftwareEngineering Software

Frequently Asked Questions Regarding Cellrox Financial Insights

What are the most recent funding rounds that Cellrox has completed, and what were the funding rounds?
Cellrox has recently completed 1 funding rounds: Series A on Jan 30, 2013.
What is the total amount of funding Cellrox has raised to date?
Cellrox has raised a total of $4.7M in funding to date.
How many funding rounds has Cellrox completed?
Cellrox has completed 1 funding rounds.
How much funding did Cellrox raise in its most recent funding round?
Cellrox raised $4.7M in its most recent funding round.
Who are the lead investors in Cellrox's latest funding round?
The lead investor in Cellrox's latest funding round was Columbia Technology Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Cellrox's history?
The largest funding round in Cellrox's history was $4.7M.
See more information about Cellrox